Cabaletta Bio, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
169.5M
on 2026-08-07, from 48.2M on 2024-03-31 10-Q ↗
a raise that quarter, at its price
Newest
$240.0M
S-3 of 2025-08-07. Sales under the at-the-market programme filed with it are not stated apart. S-3 ↗
$150.0M
TD Securities (USA), agreement of 2025-08-07. No at-the-market sales statement read from a 10-Q or 10-K. S-3 ↗
Warrants
53.09M
Warrants of every class as tagged in the XBRL facts on 2025-12-31, exercise price $0.00. 10-K ↗
Cash
5.8 quarters
$225.1M on 2026-06-30 ÷ $38.5M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-05-04 | Public offering | 51,725,000 | $2.90 | $150.0M | 424B5 ↗ |
| 2025-06-12 | Public offering incl. 10.80M pre-funded, with warrants at $2.50 | 50,000,000 | $2.00 | $100.0M | 424B5 ↗ |